Thalidomide complete remission in Schnitzler syndrome

Worm M, Kolde G

Br J Dermatol 148(3):601-2 · 2003

Grade Ccase seriesn=2engVerified
DOI ↗PubMed ↗

Abstract

[Abstract not available]

Key Findings

  • ●Thalidomide complete remission in 2 patients
  • ●Limited by polyneuropathy risk

Subject Classification

HumansImmunosuppressive AgentsInterleukin-6Schnitzler SyndromeThalidomideTreatment OutcomeTumor Necrosis Factor-alpha

Referenced in (1 disease)

Schnitzler Syndrome

Validation history

Full log →
  1. passsource metadataJun 1, 2026, 04:40 PMby pubmed-api

    Stored DOI was incorrect; corrected to the PubMed-registered DOI (verified to resolve to this article).

    tools: pubmed.esummary, crossref.works

ID: pmid-12653766DOI: 10.1046/j.1365-2133.2003.05209_9.xPMID: 12653766